FTC says it wants more information about $43B Pfizer-Seagen deal

The Fed­er­al Trade Com­mis­sion wants more in­for­ma­tion on Pfiz­er’s takeover of Seagen be­fore it will make a rul­ing on whether it will clear the $43 bil­lion deal.

The FTC’s ac­tion, known as a sec­ond re­quest for in­for­ma­tion, may stretch the time it takes the deal to close, though Seagen said in a se­cu­ri­ties fil­ing on Fri­day the the com­pa­nies ex­pect the deal to close at the end of this year or the first part of 2024. Pfiz­er has sent sig­nals that it ex­pect­ed such a re­quest from an­titrust reg­u­la­tors, though the drug­mak­er has al­so said it hasn’t seen signs that the FTC will ul­ti­mate­ly try to block the ac­qui­si­tion.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN